Medical Stocks: AIM ImmunoTech vs. Cullinan Therapeutics

miércoles, 28 de enero de 2026, 11:59 am ET1 min de lectura
AIM--
CGEM--

AIM ImmunoTech Inc. (AIM) is a medical stock with a Zacks Rank of #1 (Strong Buy) and a year-to-date return of 7.1%. The Medical sector has an average return of 7.1%, and AIM outperforms the sector in terms of year-to-date returns. Cullinan Therapeutics (CGEM) is another medical stock with a year-to-date return of 19.2% and a Zacks Rank of #2 (Buy). Both stocks are expected to continue their solid performance.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios